Monday, August 29, 2022 5:40:18 PM
No one is jumping at us offering anything right now.
You have zero idea and no clue about what is or has been taking place. Personally I suspect NW Bio has been approached and one of two things are happening or have happened.
1) Partnership is being ironed out as we speak
2) Whatever was offered was rejected, and NW Bio is going at this alone.
I am leaning towards #1. But it's truly anyone's guess. One thing I am 100% positive of: that talks are or have been taking place. Do you honestly think the journal in the reason for the silence period? I dont. Its part of it, but not the whole reason. JV Partnerships talks don't happen and get signed and sealed overnight. Its called "negotiation" for a reason. These types of talks/deals can take time particularly as trials get deeper into Phase 2/3s. Its my suspicion the push for manufacturing was directly related to these talks (you cant make money if cant cant produce the vaccine and meet demand, for both GBM and other cancers eventually) and MHRA Certification and MAA application are both part of some sort of milestone related to such talks. All my guess but backed by similar situations I have experienced with other equity's I have invested in. Big Pharma knows what is happening, make no mistake about it, and they want a piece of the pie. The bigger question for me now is, how big of a piece do they get? That I cannot answer.
-Fireman
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
